Elevated hypothalamic/midbrain serotonin (monoamine) transporter availability in depressive drug-naive children and adolescents. (Q51375215)

4 April 2018

title

Elevated hypothalamic/midbrain serotonin (monoamine) transporter availability in depressive drug-naive children and adolescents. (English)

1 reference

4 April 2018

0 references

Dahlström M

1

1 reference

4 April 2018

Ahonen A

2

1 reference

4 April 2018

Ebeling H

3

1 reference

4 April 2018

Torniainen P

4

1 reference

4 April 2018

Heikkilä J

5

1 reference

4 April 2018

Moilanen I

6

1 reference

4 April 2018

language of work or name

English

0 references

publication date

1 September 2000

1 reference

4 April 2018

published in

Molecular Psychiatry

1 reference

4 April 2018

volume

5

1 reference

4 April 2018

issue

5

1 reference

4 April 2018

page(s)

514-522

1 reference

4 April 2018

Monoamines and abnormal behaviour. A multi-aminergic perspective

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000766

Imaging D2 receptor occupancy by endogenous dopamine in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000766

Neurotransmitter transporters (plus): a promising new gene family

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000766

Receptor sensitivity and the mechanism of action of antidepressant treatment. Implications for the etiology and therapy of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000766

Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000766

Polymorphism in serotonin transporter gene associated with susceptibility to major depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000766

Single-photon emission tomography imaging of monoamine transporters in impulsive violent behaviour

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000766

Reduced central serotonin transporters in alcoholism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000766

Reduced brain serotonin transporter availability in major depression as measured by [123I]-2 beta-carbomethoxy-3 beta-(4-iodophenyl)tropane and single photon emission computed tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000766

Adult outcomes of childhood and adolescent depression. I. Psychiatric status

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000766

Subgenual prefrontal cortex abnormalities in mood disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000766

Iodine-123 labeled nor-beta-CIT as a potential tracer for serotonin transporter imaging in the human brain with single-photon emission tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000766

Differential kinetics of [123I]beta-CIT binding to dopamine and serotonin transporters.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000766

SPECT imaging of dopamine and serotonin transporters with [123I]?-CIT. Binding kinetics in the human brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000766

Platelet serotonin and plasma tryptophan decreases in endogenous depression. Clinical, therapeutic, and biological correlations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000766

Studies on the serotonin uptake binding site in major depressive disorder and control post-mortem brain: neurochemical and clinical correlates

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000766

Tritiated imipramine binding sites are decreased in the frontal cortex of suicides.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000766

5-HT uptake sites and 5-HT2 receptors in brain of antidepressant-free suicide victims/depressives: increase in 5-HT2 sites in cortex and amygdala

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000766

A double-blind, randomized, placebo-controlled trial of fluoxetine in children and adolescents with depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000766

A neural substrate of prediction and reward

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000766

Relationship between subjective effects of cocaine and dopamine transporter occupancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000766

Neuropsychological profile linked to low dopamine: in Alzheimer's disease, major depression, and Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000766

Role of the dopaminergic system in depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000766

Dopamine transporter availability and depressive symptoms during alcohol withdrawal

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000766

Role of serotonin in the paradoxical calming effect of psychostimulants on hyperactivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000766

SPECT imaging of dopamine and serotonin transporters with [123I]beta-CIT: pharmacological characterization of brain uptake in nonhuman primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000766

PET study of [11C]beta-CIT binding to monoamine transporters in the monkey and human brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000766

[125I]RTI-55 binding to cocaine-sensitive dopaminergic and serotonergic uptake sites in the human brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000766

The interaction between mood and cognitive function studied with PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000766

[125I] beta-CIT-FE and [125I] beta-CIT-FP are superior to [125I] beta-CIT for dopamine transporter visualization: autoradiographic evaluation in the human brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000766

Homovanillic and 5-Hydroxyindoleacetic Acid in Cerebrospinal Fluid of Depressed Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000766

Positron emission tomography measurement of cerebral metabolic correlates of tryptophan depletion-induced depressive relapse

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000766

In vivo association between alcohol intoxication, aggression, and serotonin transporter availability in nonhuman primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000766

Depressive comorbidity in children and adolescents: empirical, theoretical, and methodological issues

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000766

Adolescent depressive symptoms as predictors of adult depression: moodiness or mood disorder?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000766

?-CIT SPECT demonstrates blockade of 5HT-uptake sites by citalopram in the human brain in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000766

Visualizing dopamine and serotonin transporters in the human brain with the potent cocaine analogue [125I]RTI-55: in vitro binding and autoradiographic characterization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000766

7 January 2021

Monoamine metabolites in CSF and suicidal behavior

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000766

7 January 2021

Platelet and whole blood serotonin content in depressed inpatients: correlations with acute and life-time psychopathology

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000766

7 January 2021

Plasma prolactin changes following fenfluramine in depressed patients compared to controls: an evaluation of central serotonergic responsivity in depression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000766

7 January 2021

Increased serotonin-2 binding sites in frontal cortex of suicide victims

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000766

7 January 2021

Increase in serotonin-1A autoreceptors in the midbrain of suicide victims with major depression-postmortem evidence for decreased serotonin activity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000766

7 January 2021

The efficacy of selective serotonin re-uptake inhibitors in depression: a meta-analysis of studies against tricyclic antidepressants

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000766

7 January 2021

Neuroendocrine response to L-5-hydroxytryptophan challenge in prepubertal major depression. Depressed vs normal children

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000766

7 January 2021

Neuroendocrine response to 5-hydroxy-L-tryptophan in prepubertal children at high risk of major depressive disorder

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000766

7 January 2021

The mesolimbic dopamine system as a target for rapid antidepressant action.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000766

7 January 2021

Identifiers

DOI

10.1038/SJ.MP.4000766

1 reference

4 April 2018

1 reference

4 April 2018